MUNIX was used to test therapeutic response to intravenous immunoglobulins (IVIg) in multifocal motor neuropathy (MMN) patients. MUNIX sum-score was lower in MMN patients than in healthy controls. MUNIX sum-score improved quickly after intravenous immunoglobulin treatment in MMN.